# Vascular Dysfunction in Diabetes: Genes and Hormones

> **NCT01511042** · — · TERMINATED · sponsor: **Brigham and Women's Hospital** · enrollment: 100 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** Para-aminohippuric Acid
- **DRUG:** Angiotensin II
- **DRUG:** Norepinephrine

## Key facts

- **NCT ID:** NCT01511042
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 1999-12
- **Primary completion:** 2020-01
- **Final completion:** 2020-06
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2022-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01511042

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01511042, "Vascular Dysfunction in Diabetes: Genes and Hormones". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT01511042. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*